...SIX:NOVN). Other companies in the target space include NodThera Ltd., which is targeting NLRP3, and Quench Bio...

...Emerging from stealth Monday with a $50 million A round, Quench Bio is targeting the nexus of...
...new investor AbbVie Ventures. Atlas Venture and Arix Bioscience plc (LSE:ARIX), which co-founded and seeded Quench Bio...
...domain containing 4; NLRP3 (NALP3; CIAS1) - NLR family pyrin domain containing 3 COMPANY PROFILE Quench Bio...

...Richon is president and CEO of Ribon Therapeutics Inc. (Lexington, Mass.); Truex is CEO of Quench Bio...

...Atlas Venture-backed start-up Quench Bio has partnered with a Max Planck Institute for Infection Biology team to...